Picture of Santhera Pharmaceuticals Holding AG logo

SANN — Santhera Pharmaceuticals Holding AG News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: Santhera And Cold Spring Harbor Laboratory To Investigate Lonodelestat In COVID-19-Related ARDS

April 27 (Reuters) - SANTHERA PHARMACEUTICALS HOLDING AG
 SANN.S :
    * SANTHERA AND COLD SPRING HARBOR LABORATORY TO INVESTIGATE
LONODELESTAT (POL6014) IN COVID-19-RELATED ACUTE RESPIRATORY
DISTRESS SYNDROME

Source text for Eikon:  ID:nGNEbC4yZf 
Further company coverage:  SANN.S 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Santhera Pharmaceuticals Holding AG

See all news